Anjali Singh &Amp;Amp; Subrata Panda

Stories by Anjali Singh &Amp;Amp; Subrata Panda

Mahindra e-SUVs Can Now Drive Upto 500 km On Single Charge

Mahindra e-SUVs Can Now Drive Upto 500 km On Single Charge

Rediff.com   11 Jul 2025

Customers who have already booked earlier variants will also have the option to upgrade to the 79 kWh battery version.

Govt urges banks to close inoperative Jan Dhan accounts

Govt urges banks to close inoperative Jan Dhan accounts

Rediff.com   7 Jul 2025

State-owned banks have received guidance from the government to close Jan Dhan accounts whose beneficiaries are unwilling to keep them active, amid rising instances of such accounts being misused by fraudsters as mule accounts to defraud people, people aware of the development said.

Need to shift from fortnightly to real-time credit reporting: RBI DG

Need to shift from fortnightly to real-time credit reporting: RBI DG

Rediff.com   3 Jul 2025

There is a need for real-time or near real-time credit reporting, instead of the current fortnightly system, to improve underwriting precision, enable timely reflection of borrower actions such as loan closures or repayments, and deliver a superior consumer experience, Deputy Governor of the Reserve Bank of India (RBI), M Rajeshwar Rao said on Wednesday.

AI 171 Crash: Insurance Cost: $475 Million

AI 171 Crash: Insurance Cost: $475 Million

Rediff.com   1 Jul 2025

'$125 million for the hull and the remaining of over $350 million for liability.'

Indian pharma eyes US gains as $63.7 bn patent cliff nears

Indian pharma eyes US gains as $63.7 bn patent cliff nears

Rediff.com   30 Jun 2025

The Indian pharmaceutical industry is likely to benefit from a major wave of patent expiries in the US, as small-molecule drugs worth $63.7 billion are expected to go off-patent between 2025-29, a 65 per cent rise over the previous five years, according to a report by Antique stock broking limited.

$150 Million Insurance Claims Loom After AI 171 Crash

$150 Million Insurance Claims Loom After AI 171 Crash

Rediff.com   23 Jun 2025

The claims will include three kinds of liabilities: Damage to the aircraft; loss of lives who were aboard the aircraft; including the crew members; and third-party liability because of loss of lives where the aircraft crashed; and cargo liability.

'The demand for health insurance is fine'

'The demand for health insurance is fine'

Rediff.com   22 Jun 2025

'The retail industry is still growing in double digits.'

'Federal Bank Has To Now Play Test Matches'

'Federal Bank Has To Now Play Test Matches'

Rediff.com   21 Jun 2025

'The brand, the team, and the people have to make the transition from playing league matches to Test matches.'

Hospitals Boost IT Spend to Fight Cyber Threats

Hospitals Boost IT Spend to Fight Cyber Threats

Rediff.com   20 Jun 2025

The growing caution among hospitals is being driven by a rise in double-extortion ransomware attacks, AI-enabled phishing, deepfake fraud, and vulnerabilities in connected medical devices.

Change of stance to neutral doesn't mean pause on rate cut: Economists

Change of stance to neutral doesn't mean pause on rate cut: Economists

Rediff.com   18 Jun 2025

The change in stance to neutral from accommodative in the June monetary policy meeting does not necessarily signal that the Reserve Bank of India's (RBI's) rate setting body - monetary policy committee (MPC) - will go on a prolonged pause on rate cuts going forward, believe experts.

TaMo eyes 40% CV, 16% PV market share

TaMo eyes 40% CV, 16% PV market share

Rediff.com   17 Jun 2025

Tata Motors (TaMo) is aiming to gain market share across its passenger vehicle (PV) and commercial vehicle (CV) businesses - targeting a 40 per cent share in CVs and a 16 per cent share in PVs by 2027. Meanwhile, it has already achieved earnings before interest, tax, depreciation, and amortisation (Ebitda) breakeven in its electric vehicle (EV) business at 1.2 per cent (up 830 basis points), ahead of its target of 2025-26 (FY26).

Rare earth inventories may run dry by mid-July

Rare earth inventories may run dry by mid-July

Rediff.com   13 Jun 2025

Inventories of rare earth magnets used in critical automotive components - particularly electric vehicle (EV) traction motors and power steering systems - could run dry by mid-July this year, according to rating agency Icra.

HDFC Bank to pursue legal remedies against Mehta family of Lilavati Trust

HDFC Bank to pursue legal remedies against Mehta family of Lilavati Trust

Rediff.com   9 Jun 2025

HDFC Bank on Sunday said that it will "pursue all lawful remedies" to recover public funds and address the retaliatory actions taken by the Mehta family of the Lilavati Kirtilal Mehta Medical (LKMM) Trust, which has filed a complaint against the bank's managing director (MD) & chief executive officer (CEO) Sashidhar Jagdishan alleging financial fraud.

Foreign investment in Indian corporate bonds hits 10-year high in May

Foreign investment in Indian corporate bonds hits 10-year high in May

Rediff.com   7 Jun 2025

Foreign investment in bonds issued by Indian corporates touched a 10-year high in May at 20,996 crore, driven by $3.35 billion fundraise by the Shapoorji Pallonji (SP) group, which saw infusion from Deutsche Bank, BlackRock, Morgan Stanley, Davidson Kempner, and Cerberus Capital, among others. The SP group sold three-year bonds, offering 19.75 per cent yield compounded annually and payable at maturity.

'Ready To Launch 5 products In 18 Months'

'Ready To Launch 5 products In 18 Months'

Rediff.com   5 Jun 2025

'We recently launched Yesintek in the immunology space.'

LIC picks up Adani Ports' entire Rs 5K cr issue

LIC picks up Adani Ports' entire Rs 5K cr issue

Rediff.com   30 May 2025

State-owned Life Insurance Corporation (LIC) on Thursday entirely subscribed to the Rs 5,000 crore bond issue of Adani Ports and Special Economic Zone (APSEZ) at a coupon rate of 7.75 per cent, said sources privy to the development.

Sun Pharma Q4 profit down 19% at Rs 2,149.8 cr, revenue up 8%

Sun Pharma Q4 profit down 19% at Rs 2,149.8 cr, revenue up 8%

Rediff.com   23 May 2025

India's largest drug maker Sun Pharmaceutical on Thursday posted a decline of 19 per cent year-on-year (Y-o-Y) for its consolidated net profit for the fourth quarter of the financial year 2025 (Q4FY25) at Rs 2,149.8 crore. Meanwhile, its revenue from operations rose by 8 per cent at Rs 12,958.8 crore.

Lasik Surgery Market Eyes 2X Growth In 5 Years

Lasik Surgery Market Eyes 2X Growth In 5 Years

Rediff.com   20 May 2025

India currently performs around 6,00,000 to 7,00,000 laser-assisted in situ keratomileusis (Lasik) and refractive procedures a year, and the uptake is accelerating.

'Yes Bank has solved the asset quality problem'

'Yes Bank has solved the asset quality problem'

Rediff.com   17 May 2025

'Now we have one of the best asset qualities in the industry.'

Medtech MNCs bet big on localisation

Medtech MNCs bet big on localisation

Rediff.com   12 May 2025

Several multinational medical device makers are focusing on deepening their presence in India by expanding their local manufacturing footprint and research capabilities, a move that can catapult India into a strategic hub for the medical technology (medtech) industry. Among those increasing their reach in the country are Siemens Healthineers and Philips, signalling a broader shift from India being only a sales destination to becoming a global production and innovation base.